(Q38795321)

1 July 2019

title

Murine Models of Epstein-Barr Virus-Associated Lymphomagenesis (English)

1 reference

1 July 2019

1 reference

1 reference

Elshafa Hassan Ahmed

1

1 reference

1 July 2019

Robert A Baiocchi

series ordinal

2

1 reference

1 July 2019

publication date

1 January 2016

1 reference

1 July 2019

number of pages

8

1 reference

inferred from page(s)

published in

ILAR Journal

1 reference

1 July 2019

volume

57

1 reference

1 July 2019

issue

1

1 reference

1 July 2019

page(s)

55-62

1 reference

1 July 2019

Posttransplantation lymphoproliferative disorders

cites work

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV074

Low-dose interleukin 2 prevents the development of Epstein-Barr virus (EBV)-associated lymphoproliferative disease in scid/scid mice reconstituted i.p. with EBV-seropositive human peripheral blood lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV074

A severe combined immunodeficiency mutation in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV074

The SCID mouse mutant: definition, characterization, and potential uses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV074

EBV-specific cytotoxic T lymphocytes protect against human EBV-associated lymphoma in scid mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV074

Determining the Climatic Limitations of a Children's Cancer Common in Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV074

Epstein-Barr virus induces aggressive lymphoproliferative disorders of human B cell origin in SCID/hu chimeric mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV074

Human natural killer cells prevent infectious mononucleosis features by targeting lytic Epstein-Barr virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV074

Epstein-Barr virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV074

Epstein-Barr virus: an important vaccine target for cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV074

T cells or active Epstein-Barr virus infection in the development of lymphoproliferative disease in human B cell-injected severe combined immunodeficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV074

21 January 2018

Herpesvirus systematics

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV074

The rising challenge of non-AIDS-defining cancers in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV074

Identification of novel rodent herpesviruses, including the first gammaherpesvirus of Mus musculus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV074

Lymphocryptovirus phylogeny and the origins of Epstein-Barr virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV074

THE BEHAVIOUR AND MORPHOLOGY OF A SECOND TISSUE CULTURE STRAIN (EB2) OF LYMPHOBLASTS FROM BURKITT'S LYMPHOMA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV074

Direct demonstration of persistent Epstein-Barr virus gene expression in peripheral blood of infected common marmosets and analysis of virus-infected tissues in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV074

A mouse model for infectious mononucleosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV074

Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV074

Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV074

How I treat EBV lymphoproliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV074

Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B-17 scid/scid mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV074

A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV074

An Epstein-Barr Virus (EBV) mutant with enhanced BZLF1 expression causes lymphomas with abortive lytic EBV infection in a humanized mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV074

The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV074

CD141+ dendritic cells produce prominent amounts of IFN-α after dsRNA recognition and can be targeted via DEC-205 in humanized mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV074

Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV074

Lymphoma in cotton-top marmosets after inoculation with Epstein-Barr virus: tumor incidence, histologic spectrum antibody responses, demonstration of viral DNA, and characterization of viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV074

RAG-1-deficient mice have no mature B and T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV074

Viral pathogenesis in hu-PBL-SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV074

Human-mouse lymphoid chimeras: host-vs.-graft and graft-vs.-host reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV074

CD4+ T cell responses in the immune control against latent infection by Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV074

The global health burden of infection-associated cancers in the year 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV074

A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV074

The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV074

Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV074

A novel animal model of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in humanized mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV074

RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV074

Humanized NOD/LtSz-scid IL2 receptor common gamma chain knockout mice in diabetes research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV074

Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV074

Priming of protective T cell responses against virus-induced tumors in mice with human immune system components

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV074

Transgenic expression of human signal regulatory protein alpha in Rag2-/-gamma(c)-/- mice improves engraftment of human hematopoietic cells in humanized mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV074

Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV074

Anti-SCID mouse reactivity shapes the human CD4+ T cell repertoire in hu-PBL-SCID chimeras

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV074

Human mature T cells that are anergic in vivo prevail in SCID mice reconstituted with human peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV074

The human immune system in hu-PBL-SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV074

Development of a human adaptive immune system in cord blood cell-transplanted mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV074

Lymphoproliferative disease in human peripheral blood mononuclear cell-injected SCID mice. I. T lymphocyte requirement for B cell tumor generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV074

EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV074

A new humanized mouse model of Epstein-Barr virus infection that reproduces persistent infection, lymphoproliferative disorder, and cell-mediated and humoral immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV074

Transfer of a functional human immune system to mice with severe combined immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV074

Essential role for T cells in human B-cell lymphoproliferative disease development in severe combined immunodeficient mice

21 January 2018

1 reference

12 December 2020

GM-CSF and IL-2 induce specific cellular immunity and provide protection against Epstein-Barr virus lymphoproliferative disorder

1 reference

12 December 2020

Experimental treatment of Epstein-Barr virus-associated primary central nervous system lymphoma.

1 reference

12 December 2020

Heterogeneity among Epstein-Barr virus-seropositive donors in the generation of immunoblastic B-cell lymphomas in SCID mice receiving human peripheral blood leukocyte grafts

1 reference

12 December 2020

Human B-cell lymphoma in severe combined immunodeficient mice after active infection with Epstein-Barr virus

1 reference

12 December 2020

EBV-induced human B cell lymphomas in hu-PBL-SCID mice

1 reference

12 December 2020

Viral Infection in the Renal Transplant Recipient

1 reference

12 December 2020

Creation of "humanized" mice to study human immunity

1 reference

12 December 2020

EBV-associated B-cell lymphomas following transfer of human peripheral blood lymphocytes to mice with severe combined immune deficiency.

1 reference

12 December 2020

Characterization of Epstein-Barr virus-induced lymphoproliferation derived from human peripheral blood mononuclear cells transferred to severe combined immunodeficient mice

1 reference

12 December 2020

EBV Infection of Mice with Reconstituted Human Immune System Components

1 reference

12 December 2020

Epidemiology of Hodgkin's disease

1 reference

12 December 2020

Lymphomagenesis in the SCID-hu mouse involves abundant production of human interleukin-10

1 reference

12 December 2020

Adoptive transfer of cytotoxic T lymphocytes for the treatment of transplant-associated lymphoma

1 reference

12 December 2020

Characteristics of human EBV-specific cytotoxic T lymphocytes utilized for adoptive immunotherapy of EBV-induced lymphoproliferations in xenografted SCID mice

1 reference

12 December 2020

The use of an anti-CD3 immunotoxin to prevent the development of lymphoproliferative disease in SCID/PBL mice

1 reference

12 December 2020

Identifiers

DOI

10.1093/ILAR/ILV074

1 reference

1 July 2019

PMC publication ID

6302257

1 reference

1 July 2019

PubMed publication ID

27034395

1 reference

1 July 2019